BXPHARMA.DS Shariah Compliance
Screening Methodology: AAOIFI
UNLOCK FOR FREE
Last Updated: October 17, 2025
Report Source: 2025 2nd Quarter Report
B
Beximco Pharmaceuticals Ltd. Stock Analysis BXPHARMA.DS
Germany Health Care Small Cap Report: Beximco Pharmaceuticals Ltd. engages in the business of manufacturing and marketing generic pharmaceuticals formulation products covering a wide range of therapeutic categories. The firm is engaged in manufacturing and marketing of generic pharmaceutical formulation products covering a range of therapeutic categories. The company offers products in different dosage forms, including Solid, Liquid, Cream and Ointment, Suppositories, Metered Dose Inhaler, Dry Powder Inhaler, Nasal Spray, Sterile, Lyophilized Injectable and Large Volume Intravenous Fluids. Besides formulation products, the Company also manufactures APIs and renders contract manufacturing services to other companies. Products of the Company are sold in domestic and international markets. The subsidiaries of the Company include Nuvista Pharma Limited (NPL), Synovia Pharma PLC (SPP), Beximco Pharma API Limited (BPAL).
Read More Beximco Pharmaceuticals Ltd (BXPHARMA.DS) Chart
Financial Metrics & Statements of Beximco Pharmaceuticals Ltd (BXPHARMA.DS)
FAQ's for Beximco Pharmaceuticals Ltd (BXPHARMA.DS)
- According to Musaffa’s Shariah screening methodology, Beximco Pharmaceuticals Ltd (BXPHARMA.DS) is currently classified as HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
Related Halal Stocks to Beximco Pharmaceuticals Ltd (BXPHARMA.DS)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
